Table 12: Postoperative lumbar epidural opioid versus placebo or systemic analgesia

Table 12: Postoperative (+/- before end of surgery) lumbar epidural opioid versus placebo or systemic analgesia


















































Study


n treatment/


Control


Comparison


Supplemental analgesic


VAS scores and type of pain, where specified


Time to first analgesic request


Use of supplemental analgesic


Other important outcomes


Hendolin 1996


(LoE 1)


10/11


IM saline pre-op and postop epidural morphine (4 mg) + 3 mg 10 h later (EpOp) vs. IM saline pre-op and epidural saline postop and 10 h later (Cont)


Postop: PCA-fentanyl, IV


EpOp superior during the 1st 6 h (p<0.001), but NS at 6–20 h


__


Mean PCA-fentanyl consumption: EpOp superior during the 1st 6 h (p<0.01) and at 14–20 h; cumulative fentanyl consumption over 20 h: EpOp superior (p<0.01)


PONV


NS


Complications


Pruritus, urinary retention, respiratory depression: NS


Klasen 1999


(LoE 1)


10/10


Postop epidural boluses of morphine (2.5 mg), on request (EpOp) vs. PCA-morphine, IV only (Cont)


Not reported


NS over 24 h postop


__


Morphine consumption: EpOp superior at 24 h (mean EpOp requirement was 17% of Cont requirement; p value not reported)


PONV


NS


Complications


Dizziness, pruritus: NS


Nielsen 1989


(LoE 1)


9/10


Epidural morphine (2–6 mg), 3 times daily for 10 days (EpOp) vs. IM ketobemidone for 5 days (Cont)


Postop: oral paracetamol (1 g), 4 times daily


EpOp superior on days 1 and 10 (p<0.05, in both cases)


__


Not reported


PONV


3 patients vs. 1


Functional outcomes


Range of motion: NS


Complications


Pruritus: 1 patient vs. 0; urinary retention: 2 patients vs. 0


Weller 1991


(LoE 2)


15/15


Epidural morphine (3 ml 0.1%) + saline (2 ml), 1 h before end of surgery + 0.1% morphine (2 ml) in recovery room if required, repeated 12 h later (EpOp) vs. IV morphine in recovery room until VAS<4 then PCA-morphine IV (Cont)


Postop: PCA-morphine, IV


VAS score for pain at time of assessment (i.e. at 6, 18 and 24 h):


NS; VAS score for pain (recalled) since time of last assessment: EpOp superior (p<0.05)


__


Loading dose of morphine required for VAS<4 in recovery room: EpOp superior (p<0.05); 24 h total morphine consumption: EpOp superior (p<0.05)


PONV


NS


Complications


Sedation: NS; pruritus: Cont superior (p<0.05); minimum respiratory rate: Cont superior (p<0.05), but no clinically important respiratory depression in EpOp